Biotech Blog Archives: September 2003
next page ·
previous page
24 September 2003
Definitions Impede Stem-Cell Work
Definitions Impede Stem-Cell Work
The medical promise of embryonic stem-cell research has been plagued by ethical controversy. Now, an apparent way to get stem cells without destroying human embryos is hung up by federal policy.
continue reading... » 0 Comments
24 September 2003
Bioterror Brain Drain
Bioterror Brain Drain
“Infectious-disease specialists are following the big bucks to Washington’s new multibillion-dollar program on bioterrorism research�but at what human cost? “
continue reading... » 0 Comments
24 September 2003
A dose of reality
A dose of reality
“The FDA yesterday opened two days of hearings on the subject of consumer advertising, for the first time publicly presenting survey data that shows prescription advertising is generating widespread skepticism among doctors.”
continue reading... » 0 Comments
24 September 2003
Naturally blonde, brunette…
Naturally blonde, brunette…
“Designer ‘therapies’ could one day be helping to restore our hair to its former colour and texture”
continue reading... » 0 Comments
24 September 2003
Venter Announces $500K Prize for Significant Advances Toward $1,000 Genome
Venter Announces $500K Prize for Significant Advances Toward $1,000 Genome
“Just before lunch today at the GSAC conference, Craig Venter stood before the crowd and announced a mouth-watering proposition: a $500,000 Genomic Technology Prize to be awarded by the J. Craig Venter Science Foundation to a person or organization that develops technology ‘to significantly advance’ [...]
continue reading... » 0 Comments
23 September 2003
The Odd Couple - CombinatoRx brings matchmaking to drug discovery and development
The Odd Couple - CombinatoRx brings matchmaking to drug discovery and development
While almost everyone in the drug industry is looking for ways to speed new drugs to market, CombinatoRx has taken a particularly pragmatic approach: Rather than looking for new drugs, it is searching for novel combinations of existing drugs with synergistic effects.
